“…Different combinations of subunits define nAChR subtypes and confer distinguishing biophysical and pharmacological characteristics to the receptor. The a4b2 nAChRs are the predominant heteromeric nAChRs in the mammalian brain (Whiting and Lindstrom, 1987;Flores et al, 1992;Mao et al, 2008) and are thought to mediate important physiologic actions of acetylcholine (ACh) and pharmacological effects of nicotine related to attention and cognition (Picciotto et al, 1995;Guillem et al, 2011;Lozada et al, 2012;Paolone et al, 2013;Oda et al, 2014) and affective states (Mineur and Picciotto, 2010;Turner et al, 2010;Brunzell, 2012, 2015;Hussmann et al, 2014). In addition to their roles in normal central nervous system physiology, considerable evidence points to the involvement of these receptors in nicotine addiction and dependence (Marks et al, 1983;Schwartz and Kellar, 1983;Benwell et al, 1988;Flores et al, 1992Flores et al, , 1997Perry et al, 1999;Staley et al, 2006;Wüllner et al, 2008;Marks et al, 2011).…”